Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-28

Clinical Trial Update: Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates how pretarsal and preseptal Botulinum Toxin Type A injections affect tear function in people with hemifacial spasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Khon Kaen University | Conditions: Hemifacial Spasm | Phase 2 | Status: UNKNOWN